Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-07 for Actinic Keratosis
NCT02654717Phase 2Completed
- Sponsor
- Promius Pharma
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib topical in actinic keratosis (AK), sponsored by Promius Pharma. Started Nov 2015; status: completed.
02
Drugs
celecoxib topical
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02654717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654717.